Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-16 of 16 for your search:
Drug:
becatecarin
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II Study of Rebeccamycin Analogue in Children With Relapsed or Refractory Neuroblastoma
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
Children
Sponsor:
NCI
Protocol IDs:
MSKCC-98095
, NCI-T98-0041, NCT00003737, T98-0041
2.
Phase II Study of Rebeccamycin Analogue in Patients With Advanced Renal Cell Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
WSU-C-2063
, NCI-T99-0113, NCT00005027, T99-0113
3.
Phase II Study of Rebeccamycin Analogue in Patients With Metastatic or Locally Recurrent Colorectal Cancer (Summary Last Modified 04/2002)
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
AECM-T99-0109
, NCI-T99-0109, NCT00005085, T99-0109
4.
Phase II Randomized Study of Rebeccamycin Analogue in Women With Stage IIIB or IV Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
DFCI-99283
, CWRU-DFCI-1199, NCI-197, NCT00005817, 197
5.
Phase II Study of Rebeccamycin Analogue in Patients With Advanced Hepatobiliary Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CWRU-2299
, NCI-96, NCT00005997, 96
6.
Phase II Randomized Study of Rebeccamycin Analogue Via 1 Infusion Versus 5 Daily Infusions in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
Not specified
Sponsor:
NCI
Protocol IDs:
CWRU-1599
, NCI-91, NCT00006017, 91
7.
Phase II Study of Rebeccamycin Analogue in Children With Solid Tumors or Non-Hodgkin's Lymphoma
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
21 and under at original diagnosis
Sponsor:
NCI
Protocol IDs:
COG-P9963
, P9963, NCT00006102
8.
Phase II Study of Rebeccamycin Analogue in Patients With Refractory Stage III or IV Ovarian Epithelial Cancer (Summary Last Modified 11/2001)
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
21 and over
Sponsor:
NCI
Protocol IDs:
NU-NCI-00G1
, NCI-1132, NCT00006262, 1132
9.
Phase II Study of Rebeccamycin Analogue as Second-Line Therapy in Patients With Limited or Extensive Stage Small Cell Lung Cancer That Relapsed After Prior First-Line Chemotherapy
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CASE-CWRU-1503
, NCI-1990, 1990, NCT00084487, CASE-1503
10.
Phase I Study of a Rebeccamycin Analogue in Patients With Metastatic Epithelial and Mesenchymal Tumors and Malignant Lymphomas (Summary Last Modified 06/2000)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
WCCC-CO-9493
, NCI-T94-0118H, T94-0118
11.
Phase I Study of a Rebeccamycin Analogue Bolus Infusion for Advanced Malignancies
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UTHSC-9455011077
, SACI-IDD-94-32, NCI-T94-0136D, T94-0136
12.
Phase I Study of Rebeccamycin Analogue (NSC #655649) in Children with Refractory Malignant Solid Tumors (Summary Last Modified 07/2002)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
21 and under
Sponsor:
NCI
Protocol IDs:
POG-9670
13.
Phase I Clinical and Pharmacokinetic Study of Rebeccamycin Analogue in Patients with Refractory or Recurrent Adult Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CWRU-4Y96
, NCI-T97-0002, T97-0002
14.
Phase I Study of Rebeccamycin Analogue and Cisplatin With or Without Filgrastim (G-CSF) in Patients With Advanced Malignancies
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UTHSC-IDD-98-34
, SACI-IDD-98-34, NCI-T98-0069, NCT00004189, T98-0069
15.
Phase I Study of Rebeccamycin Analogue and Oxaliplatin in Patients With Refractory Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CASE-CWRU-4Y03
, CWRU-020420, 5921, NCI-5921, NCT00086983, CASE-4Y03
16.
Phase I Study of Rebeccamycin Analogue (XL119) in Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia in Blastic Phase
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MDA-2003-0909
, NCI-5651, 5651, NCT00087204
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
